Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NBTX · against 447 other Healthcare companies of similar size
Ranked #375 of 448 · scores higher than 16% of peers
Bars: peers in each 10-point band of the profitability score39 peers with a profitability score of 10–19, including NBTX · Click a bar to see the companies
Mainly because of its return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | NBTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 423 reported | Not reported | 5.4% | — | — | 33% |
| Operating marginHigher is better · 422 reported | -33.2% | 7.1% | 16% | 33% | |
| Return on assetsHigher is better · 434 reported | -35.4% | 1.9% | 9% | 33% | |
| Return on equityHigher is better · 418 reported | Not reported | 3.4% | — | — | Context only |
| Gross marginHigher is better · 464 reported | 100.0% | 47.6% | 97% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 370 | 2.8B USD | 21 | 22 | |
| 370 | 2.2B USD | 21 | 23 | |
| 374 | 1.8B USD | 20 | 42 | |
| 375 | 815M USD | 19 | 53 | |
| 375 | 1.5B USD | 19 | 32 | |
| 375 | 758M USD | 19 | 35 | |
| 375 | 1.2B USD | 19 | 40 | |
| 379 | 2.21T KRW (≈$1.6B) | 18 | 57 | |
| 379 | 1.0B USD | 18 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score